CP-94253

Last updated
CP-94253
CP-94253 Structure.svg
Clinical data
Other namesCP94253; CP-94,253
Drug class Serotonin 5-HT1B receptor agonist
Identifiers
  • 3-(1,2,5,6-tetrahydro-4-pyridyl)-5-propoxypyrrolo[3,2-b]pyridine
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
Formula C15H19N3O
Molar mass 257.337 g·mol−1
3D model (JSmol)
  • c13nc(OCCC)ccc1[nH]cc3C2=CCNCC2
  • InChI=1S/C15H19N3O/c1-2-9-19-14-4-3-13-15(18-14)12(10-17-13)11-5-7-16-8-6-11/h3-5,10,16-17H,2,6-9H2,1H3 X mark.svgN
  • Key:KWQWBZIGHIOKIO-UHFFFAOYSA-N X mark.svgN
 X mark.svgNYes check.svgY  (what is this?)    (verify)

CP-94253 is a drug of the tetrahydropyridinylpyrrolopyridine family which acts as a potent and selective serotonin 5-HT1B receptor agonist, with approximately 25- and 40-fold selectivity over the closely related serotonin 5-HT1D and 5-HT1A receptors. [1]

It has a range of behavioral effects, based on animal testing. The effects include the following: promoting wakefulness by increasing dopamine release in the brain; [2] [3] reducing food intake and promoting satiety; [4] [5] [6] enhancing the reinforcing effects of cocaine; [7] [8] [9] [10] and possible antidepressant effects. [11] In addition, CP-94253 reduces aggression without causing sedation in rodents. [12] [13] [14] [15] [16] [17] [18] [19]

A 2021 study [20] found that "Regardless of sex, CP94253 decreased cocaine intake after abstinence and during resumption of SA [self-administration] and decreased cue reactivity" suggesting that agonism of the inhibitory 5-HT2B receptors may diminish the cognitive reward of cocaine usage and increased use of the drug without a period of abstinence may be a product of test subjects trying to achieve a previously rewarding experience through larger dosages of cocaine.

See also

References

  1. ↑ Koe KB, Nielsen JA, Macor JE, Heym J (1992). "Biochemical and behavioral studies of the 5-HT1B receptor agonist, CP-94,253". Drug Development Research. 26 (3): 241–250. doi:10.1002/ddr.430260305. S2CID   85358992.
  2. ↑ Monti JM, Monti D, Jantos H, Ponzoni A (December 1995). "Effects of selective activation of the 5-HT1B receptor with CP-94,253 on sleep and wakefulness in the rat". Neuropharmacology. 34 (12): 1647–1651. doi:10.1016/0028-3908(95)00112-3. PMID   8788962. S2CID   11872727.
  3. ↑ Iyer RN, Bradberry CW (April 1996). "Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization". The Journal of Pharmacology and Experimental Therapeutics. 277 (1): 40–47. doi:10.1016/S0022-3565(25)12836-X. PMID   8613947.
  4. ↑ Halford JC, Blundell JE (September 1996). "The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence". Physiology & Behavior. 60 (3): 933–939. doi:10.1016/0031-9384(96)00073-x. PMID   8873272. S2CID   24349948.
  5. ↑ Lee MD, Simansky KJ (June 1997). "CP-94, 253: a selective serotonin1B (5-HT1B) agonist that promotes satiety". Psychopharmacology. 131 (3): 264–270. doi:10.1007/s002130050292. PMID   9203237. S2CID   33969765.
  6. ↑ Lee MD, Kennett GA, Dourish CT, Clifton PG (October 2002). "5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253". Psychopharmacology. 164 (1): 49–60. doi:10.1007/s00213-002-1162-7. PMID   12373419. S2CID   2926575.
  7. ↑ Parsons LH, Weiss F, Koob GF (December 1998). "Serotonin1B receptor stimulation enhances cocaine reinforcement". The Journal of Neuroscience. 18 (23): 10078–10089. doi:10.1523/JNEUROSCI.18-23-10078.1998. PMC   6793270 . PMID   9822762.
  8. ↑ Przegalinski E, Filip M, Papla I, Siwanowicz J (April 2001). "Effect of serotonin (5-HT)1B receptor ligands on cocaine sensitization in rats". Behavioural Pharmacology. 12 (2): 109–116. doi:10.1097/00008877-200104000-00004. PMID   11396515.
  9. ↑ Przegaliński E, Gołda A, Frankowska M, Zaniewska M, Filip M (March 2007). "Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self-administration in rats". European Journal of Pharmacology. 559 (2–3): 165–172. doi:10.1016/j.ejphar.2006.12.012. PMID   17291490.
  10. ↑ Przegaliński E, Gołda A, Filip M (2008). "Effects of serotonin (5-HT)(1B) receptor ligands on cocaine-seeking behavior in rats". Pharmacological Reports. 60 (6): 798–810. PMID   19211971.
  11. ↑ Tatarczyńska E, Antkiewicz-Michaluk L, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E (May 2005). "Antidepressant-like effect of the selective 5-HT1B receptor agonist CP 94253: a possible mechanism of action". European Journal of Pharmacology. 516 (1): 46–50. doi:10.1016/j.ejphar.2005.04.025. PMID   15913599.
  12. ↑ Miczek KA, Fish EW, De Bold JF, De Almeida RM (October 2002). "Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems". Psychopharmacology (Berl). 163 (3–4): 434–458. doi:10.1007/s00213-002-1139-6. PMID   12373445.
  13. ↑ Bell R, Donaldson C, Gracey D (September 1995). "Differential effects of CGS 12066B and CP-94,253 on murine social and agonistic behaviour". Pharmacol Biochem Behav. 52 (1): 7–16. doi:10.1016/0091-3057(95)00077-a. PMID   7501681.
  14. ↑ Fish EW, Faccidomo S, Miczek KA (October 1999). "Aggression heightened by alcohol or social instigation in mice: reduction by the 5-HT(1B) receptor agonist CP-94,253". Psychopharmacology (Berl). 146 (4): 391–399. doi:10.1007/pl00005484. PMID   10550489.
  15. ↑ Kirilly E, Benko A, Ferrington L, Ando RD, Kelly PA, Bagdy G (February 2006). "Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats". Int J Neuropsychopharmacol. 9 (1): 63–76. doi:10.1017/S146114570500581X. PMID   16060968.
  16. ↑ De Almeida RM, Rosa MM, Santos DM, Saft DM, Benini Q, Miczek KA (May 2006). "5-HT(1B) receptors, ventral orbitofrontal cortex, and aggressive behavior in mice". Psychopharmacology (Berl). 185 (4): 441–450. doi:10.1007/s00213-006-0333-3. PMID   16550387.
  17. ↑ Bannai M, Fish EW, Faccidomo S, Miczek KA (August 2007). "Anti-aggressive effects of agonists at 5-HT1B receptors in the dorsal raphe nucleus of mice". Psychopharmacology (Berl). 193 (2): 295–304. doi:10.1007/s00213-007-0780-5. PMID   17440711.
  18. ↑ Fish EW, McKenzie-Quirk SD, Bannai M, Miczek KA (March 2008). "5-HT(1B) receptor inhibition of alcohol-heightened aggression in mice: comparison to drinking and running". Psychopharmacology (Berl). 197 (1): 145–156. doi:10.1007/s00213-007-1017-3. PMID   18071678.
  19. ↑ Wang L, Clark EA, Hanratty L, Koblan KS, Foley A, Dedic N, Bristow LJ (December 2024). "TAAR1 and 5-HT1B receptor agonists attenuate autism-like irritability and aggression in rats prenatally exposed to valproic acid". Pharmacol Biochem Behav. 245 173862. doi:10.1016/j.pbb.2024.173862. PMID   39197535.
  20. ↑ Scott SN, Garcia R, Powell GL, Doyle SM, Ruscitti B, Le T, et al. (October 2021). "5-HT1B receptor agonist attenuates cocaine self-administration after protracted abstinence and relapse in rats". Journal of Psychopharmacology. 35 (10): 1216–1225. doi:10.1177/02698811211019279. PMID   34049460. S2CID   235243643.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.